Trial Profile
Analysis for different expressed of circrnas and urine proteomics in urine exosomes of patients with mild to moderate type 2 diabetic nephropathy to be treated by Dapagliflozin
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2020
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- 04 Feb 2020 New trial record